Please assess the completion status of the following clinical trial:

Trial Title: Use of the MiCK Assay for Apoptosis in AML

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~patients with newly diagnosed acute myeloid leukemia (AML~Exclusion Criteria:

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- II (Type: None): None
- 1 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).